OneMedNet Shares Surge 99.69% on $280M Trading Volume Rank 350th in Market Activity

On August 14, 2025, OneMedNet (ONMD) surged 99.69% with a trading volume of $280 million, ranking 350th in market activity. This follows the company’s announcement of an 80% reduction in total liabilities, decreasing from $19.7 million to $6.2 million as of June 30, 2025, with an additional $1.9 million reduction in July 2025. The debt restructuring included conversions, vendor repayments, and discounted settlements, generating $5.0 million in non-operational income that contributed to $3.0 million in Q2 net income and $1.1 million year-to-date. The company also secured $3.7 million in private placements, with $1.2 million from insiders, to fund sales expansion and platform development.

Operational progress includes expanding its provider network to 1,750 sites, granting access to 136 million clinical studies. The iRWD™ platform now integrates 5 billion administrative records and claims, enhancing AI-driven de-identification, federated search, and multi-modal data integration. These upgrades position OneMedNet to address healthcare data silos and regulatory compliance challenges, strengthening its competitive edge in the real-world data market. The company also maintains a strategic Bitcoin position of 15 BTC, valued at $1.6 million, reflecting a diversified treasury approach.

CEO Aaron Green emphasized the company’s focus on leveraging its improved balance sheet and scalable platform to drive long-term value. With a strong sales funnel and capital infusion, OneMedNet aims to accelerate customer acquisition and expand its data infrastructure across healthcare and non-healthcare sectors, including finance and retail. Insider participation in fundraising underscores confidence in the restructured business model and growth trajectory.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to now delivered moderate returns. The 1-day return was 0.98%, with a total return of 31.52% over 365 days. This indicates the strategy captured some short-term momentum but was subject to market fluctuations. It performed best in June 2023, with returns of 7.02%, and worst in September 2022, with a return of -4.20%. Overall, the strategy showed volatility but a positive trend, making it suitable for traders looking for short-term opportunities.